A Prediction Model with a Combination of Variables for Diagnosis of Lung Cancer

被引:26
作者
Cai, Xiangsheng [1 ]
Chen, Lu [2 ]
Kang, Tao [3 ]
Tang, Yongming [3 ]
Lim, Teong [3 ]
Xu, Meng [2 ]
Hui, Hongxiang [1 ,3 ,4 ]
机构
[1] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China
[2] Jinan Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Guangdong, Peoples R China
[3] Dongguan SMU Metab Med Ltd Co, Dongguan, Guangdong, Peoples R China
[4] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Excellence Pancreat Dis, Los Angeles, CA 90095 USA
来源
MEDICAL SCIENCE MONITOR | 2017年 / 23卷
关键词
Early Detection of Cancer; Lung Neoplasms; Tumor Microenvironment; VOLATILE ORGANIC-COMPOUNDS; EXHALED BREATH; ELECTRONIC NOSE; BIOMARKERS; DISCRIMINATION; MARKERS; ARRAY;
D O I
10.12659/MSM.904738
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Multivariate models with a combination of variables can predict disease more accurately than a single variable employed alone. We developed a logistic regression model with a combination of variables and evaluated its ability to predict lung cancer. Material/Methods: The exhaled breath from 57 patients with lung cancer and 72 healthy controls without cancer was collected. The VOCs of exhaled breath were examined qualitatively and quantitatively by a novel electronic nose (Z-nose4200 equipment). The VOCs in the 2 groups were compared using the Mann-Whitney U test, and the baseline data were compared between the 2 groups using the chi-square test or ANOVA. Variables from VOCs and baseline data were selected by stepwise logistic regression and subjected to a prediction model for the diagnosis of lung cancer as combined factors. The receiver operating characteristic (ROC) curve was used to evaluate the predictive ability of this prediction model. Results: Nine VOCs in exhaled breath of lung cancer patients differed significantly from those of healthy controls. Four variables - age, hexane, 2,2,4,6,6-pentamethylheptane, and 1,2,6-trimethylnaphthalene - were entered into the prediction model, which could effectively separate the lung cancer samples from the control samples with an accuracy of 82.8%, a sensitivity of 76.0%, and a speci.city of 94.0%. Conclusions: The profile of VOCs in exhaled breath contained distinguishable biomarkers in the patients with lung cancers. The prediction model with 4 variables appears to provide a new technique for lung cancer detection.
引用
收藏
页码:5620 / 5629
页数:10
相关论文
共 39 条
  • [1] The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)
    Amal, Haitham
    Ding, Lu
    Liu, Bin-bin
    Tisch, Ulrike
    Xu, Zhen-qin
    Shi, Da-you
    Zhao, Yan
    Chen, Jie
    Sun, Rui-xia
    Liu, Hu
    Ye, Sheng-Long
    Tang, Zhao-you
    Haick, Hossam
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 4135 - 4146
  • [2] Amann A, 2011, EXPERT REV MOL DIAGN, V11, P207, DOI [10.1586/ERM.10.112, 10.1586/erm.10.112]
  • [3] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
  • [4] Noninvasive detection of lung cancer by analysis of exhaled breath
    Bajtarevic, Amel
    Ager, Clemens
    Pienz, Martin
    Klieber, Martin
    Schwarz, Konrad
    Ligor, Magdalena
    Ligor, Tomasz
    Filipiak, Wojciech
    Denz, Hubert
    Fiegl, Michael
    Hilbe, Wolfgang
    Weiss, Wolfgang
    Lukas, Peter
    Jamnig, Herbert
    Hackl, Martin
    Haidenberger, Alfred
    Buszewski, Boguslaw
    Miekisch, Wolfram
    Schubert, Jochen
    Amann, Anton
    [J]. BMC CANCER, 2009, 9 : 348
  • [5] The versatile use of exhaled volatile organic compounds in human health and disease
    Boots, Agnes W.
    van Berkel, Joep J. B. N.
    Dallinga, Jan W.
    Smolinska, Agnieszka
    Wouters, Emile F.
    van Schooten, Frederik J.
    [J]. JOURNAL OF BREATH RESEARCH, 2012, 6 (02)
  • [6] An electronic nose in the discrimination of patients with asthma and controls
    Dragonieri, Silvano
    Schot, Robert
    Mertens, Bart J. A.
    Le Cessie, Saskia
    Gauw, Stefanie A.
    Spanevello, Antonio
    Resta, Onofrio
    Willard, Nico P.
    Vink, Teunis J.
    Rabe, Klaus F.
    Bel, Elisabeth H.
    Sterk, Peter J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (04) : 856 - 862
  • [7] An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD
    Dragonieri, Silvano
    Annema, Jouke T.
    Schot, Robert
    van der Schee, Marc P. C.
    Spanevello, Antonio
    Carratu, Pierluigi
    Resta, Onofrio
    Rabe, Klaus F.
    Sterk, Peter J.
    [J]. LUNG CANCER, 2009, 64 (02) : 166 - 170
  • [8] Exhaled Breath Profiling Enables Discrimination of Chronic Obstructive Pulmonary Disease and Asthma
    Fens, Niki
    Zwinderman, Aeilko H.
    van der Schee, Marc P.
    de Nijs, Selma B.
    Dijkers, Erica
    Roldaan, Albert C.
    Cheung, David
    Bel, Elisabeth H.
    Sterk, Peter J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (11) : 1076 - 1082
  • [9] GORDON SM, 1985, CLIN CHEM, V31, P1278
  • [10] Differences in Exhaled Gas Profiles Between Patients with Type 2 Diabetes and Healthy Controls
    Greiter, M. B.
    Keck, L.
    Siegmund, T.
    Hoeschen, C.
    Oeh, U.
    Paretzke, H. G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (06) : 455 - 463